• News
  • SAN DIEGO
  • BioTech

DexCom cited as bellwether

CNBC stock commentator Jim Cramer on Friday cited San Diego’s DexCom Inc. (Nasdaq: DXCM) as a bellwether for the stock market, which should go into a turnaround on Wall Street within the next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
39.88
  0.57  
+ 1.45%
793,290,000
49.83
21.76

Insider Trade Data

Date Insider Shares Type Value
07/23/2014 Doubleday, Richard B 4,000 Sell $152,654
07/23/2014 Pacelli, Steven Robert 14,000 Exchange $106,820
07/23/2014 Pacelli, Steven Robert 14,000 Sell $535,986
07/23/2014 Doubleday, Richard B 4,000 Exchange $24,120
07/18/2014 Roper, Jess 8,000 Sell $288,070

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!